Raphael Pharmaceutical Inc. (RAPH) — 8-K Filings

8-K Filings (6)

• Raphael Pharma Approves $5M Stock Buyback — Aug 11, 2025 Risk: medium
  Raphael Pharmaceutical Inc. announced on August 11, 2025, that its Board of Directors approved a new stock repurchase program. The company is authorized to repu
• Raphael Pharma Relocates HQ to Israel — Jan 14, 2025 Risk: low
  Raphael Pharmaceutical Inc. announced on January 14, 2025, that its principal executive offices are located at 4 Lui Paster, Tel Aviv-Jaffa, Israel, 6803605. Th
• Raphael Pharma to Acquire Bio-Gen Innovations — Dec 30, 2024 Risk: medium
  Raphael Pharmaceutical Inc. announced on December 23, 2024, that it has entered into a definitive agreement to acquire all outstanding shares of common stock of
• Raphael Pharmaceutical Appoints New Auditor — Sep 11, 2024 Risk: medium
  Raphael Pharmaceutical Inc. announced on September 11, 2024, that it has appointed a new independent registered public accounting firm, Marcum LLP, effective Se
• Raphael Pharmaceutical Changes Executive Offices to Israel — Jun 26, 2024 Risk: low
  Raphael Pharmaceutical Inc. filed an 8-K on June 26, 2024, reporting a change in its principal executive offices to 4 Lui Paster, Tel Aviv-Jaffa, Israel, 680360
• Raphael Pharmaceutical to Acquire Bio-Gen Innovations — May 2, 2024 Risk: medium
  Raphael Pharmaceutical Inc. announced on April 30, 2024, that it has entered into a binding agreement to acquire 100% of the issued and outstanding shares of Bi

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX